|
|
(8 intermediate revisions not shown) |
Line 1: |
Line 1: |
| {{Team:Newcastle/mainbanner}} | | {{Team:Newcastle/mainbanner}} |
| | | |
| + | =Transformation of ligated ''yneA'' into pGFPrrnB and pSB1C3= |
| | | |
| + | ==Aims== |
| | | |
- | =''yneA''=
| + | To produce more colonies of the plasmid pGFPrrnB and pSB1C3 containing ''yneA'' with pGFPrrnB and pSB1C3 from[[Team:Newcastle/19_August_2010|yesterday]]. |
| | | |
- | ==Gel Extraction==
| + | ==Materials and Protocol== |
- | | + | |
- | ===Aims===
| + | |
- | | + | |
- | To purify the PCR products of digested ''yneA'', pGFPrrnB and pSB1C3 from [[Team:Newcastle/19_August_2010|yesterday]], as well as the promoter and double terminator for the ''rocF'' BioBrick.
| + | |
- | | + | |
- | ===Materials and Protocol===
| + | |
- | | + | |
- | Please refer to [[Team:Newcastle/Gel_extraction|gel extraction]] and [[TeamNewcastleNanoDrop_Spectrophotometer|nanodrop]].
| + | |
- | | + | |
- | ===Results===
| + | |
- | | + | |
- | Results of NanoDrop from gel extraction:
| + | |
- | | + | |
- | {|border=1
| + | |
- | |-
| + | |
- | ! DNA
| + | |
- | ! Concentration (ng/µl)
| + | |
- | |-
| + | |
- | ! ''yneA''
| + | |
- | ! 8.5
| + | |
- | |-
| + | |
- | ! pGFPrrnB
| + | |
- | ! 15.3
| + | |
- | |-
| + | |
- | ! pSB1C3
| + | |
- | ! 6.4
| + | |
- | |}
| + | |
- | | + | |
- | ===Discussion===
| + | |
- | | + | |
- | The concentration of ''yneA'', pGFPrrnB and pSB1C3 are not very high.
| + | |
- | | + | |
- | ===Conclusion===
| + | |
- | | + | |
- | We continue using these products for ligation.
| + | |
- | | + | |
- | ==Miniprep==
| + | |
- | | + | |
- | ===Aim===
| + | |
- | | + | |
- | To produce stocks of ''yneA'', pGFPrrnB and pSB1C3.
| + | |
- | | + | |
- | ===Materials and Protocol===
| + | |
- | | + | |
- | Please refer to [[Team:Newcastle/Qiagen_Minipreps|miniprep]] and [[TeamNewcastleNanoDrop_Spectrophotometer|nanodrop]].
| + | |
- | | + | |
- | ===Results===
| + | |
- | | + | |
- | The table below shows results of concentration (in ng/µl) from NanoDrop:
| + | |
- | | + | |
- | {|border=1
| + | |
- | |-
| + | |
- | ! Sample no.
| + | |
- | ! ''yneA''
| + | |
- | ! pGFPrrnB
| + | |
- | ! pSB1C3
| + | |
- | |-
| + | |
- | !1
| + | |
- | !432.5
| + | |
- | !238.9
| + | |
- | !126.1
| + | |
- | |-
| + | |
- | !2
| + | |
- | !347.6
| + | |
- | !230.7
| + | |
- | !107.6
| + | |
- | |-
| + | |
- | !3
| + | |
- | !380.2
| + | |
- | !390.9
| + | |
- | !121.5
| + | |
- | |-
| + | |
- | !4
| + | |
- | !377.9
| + | |
- | !236.2
| + | |
- | !112.8
| + | |
- | |}
| + | |
- | | + | |
- | ===Discussion===
| + | |
- | | + | |
- | Results from the NanoDrop show concentration values of more than 100ng/µl, which means we have obtained good concentration of DNA from the miniprep.
| + | |
- | | + | |
- | ===Conclusion===
| + | |
- | | + | |
- | We keep the miniprep products as stocks for future use.
| + | |
- | | + | |
- | | + | |
- | ==Transformation of Ligated Products==
| + | |
- | | + | |
- | ===Aims===
| + | |
- | | + | |
- | To produce more colonies of the products of ''yneA'' with pGFPrrnB and pSB1C3 from ligation [[Team:Newcastle/19_August_2010|yesterday]].
| + | |
- | | + | |
- | ===Materials and Protocol===
| + | |
| | | |
| Please refer to [[Team:Newcastle/Transformation_of_E._coli|transformation of E. coli]]. | | Please refer to [[Team:Newcastle/Transformation_of_E._coli|transformation of E. coli]]. |
| | | |
- |
| |
- | ==Ligation==
| |
- |
| |
- | ===Aims===
| |
- |
| |
- | To ligate ''yneA'' with pGFPrrnB and ''yneA'' with pSB1C3 (A repeat of [[Team:Newcastle/19_August_2010|yesterday]]).
| |
- |
| |
- | ===Materials and Protocol===
| |
- |
| |
- | Please refer to [[Team:Newcastle/Ligation|ligation]].
| |
- |
| |
- | ===Results, Discussion and Conclusion===
| |
- |
| |
- | Please refer to [[Team:Newcastle/23_August_2010|23.08.10]].
| |
- |
| |
- |
| |
- |
| |
- |
| |
- |
| |
- | ==Plating ''Bacillus subtilis'' BFS678==
| |
- | Has pMutin4 (and thus ''lacI'') integrated into the chromosome...will be useful for characterisation.. will be transforming this strain with our filamentous cell and arginase BioBricks.
| |
| | | |
| | | |
| {{Team:Newcastle/footer}} | | {{Team:Newcastle/footer}} |